Rubius Therapeutics, Inc.
RUBYDelisted Mar 28, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001709401
Rubius Therapeutics, Inc. was delisted on Mar 28, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 42 institutions reported holding it in 13F filings for Q4 2022, worth $11.2M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Rubius Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +4 vs. Q3 2021
- Shares held
- 89.2M
- +2.82M (+3.3%) vs. Q3 2021
- Total value
- $863.6M
- −$681.5M (−44.1%) vs. Q3 2021
- New holders
- 18
- 44 more added
- Sold out
- 14
- 27 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RUBY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 7 | $61.3K |
| Q4 2022 | 42 | $11.2M |
| Q3 2022 | 62 | $29.7M |
| Q2 2022 | 73 | $66.6M |
| Q1 2022 | 117 | $493.9M |
| Q4 2021 | 108 | $863.6M |
| Q3 2021 | 105 | $1.55B |
| Q2 2021 | 108 | $2.09B |
| Q1 2021 | 105 | $2.23B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Rubius Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital World Investors | 2,751,000 | $26.6M | 0.00% | +100,000+3.8% | Added |
| JPMorgan Chase & Co | 3,161,516 | $30.6M | 0.00% | +708,647+28.9% | Added |
| Vanguard Group Inc | 3,246,641 | $31.4M | 0.00% | +11,634+0.4% | Added |
| BlackRock Inc. | 3,481,801 | $33.7M | 0.00% | −2,679−0.1% | Reduced |
| Artal Group S.A. | 3,701,580 | $35.8M | 1.05% | −454,045−10.9% | Reduced |
| Baillie Gifford & Co | 4,930,859 | $47.7M | 0.03% | +237,027+5.0% | Added |
| FMR LLC | 13,479,866 | $130.5M | 0.01% | −47,627−0.4% | Reduced |
| Flagship Pioneering Inc. | 38,506,526 | $372.7M | 5.76% | 00.0% | Unchanged |
| PDT Partners, LLC | 0 | $0 | 0.00% | −65,991−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −46,076−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −40,782−100.0% | Sold out |
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −29,967−100.0% | Sold out |
| Bellwether Advisors, LLC | 0 | $0 | 0.00% | −29,383−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −25,825−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −13,879−100.0% | Sold out |
| Centaurus Financial, Inc. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,560−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −10,116−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −6,200−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −2,060−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |